Abstract:Background Primary Sjögren’s syndrome (pSS) is a commono systemic autoimmune disease, characterised by lymphocytic infiltration of the secretory glands and different extraglandular manifestations. Besides haematological disorders are prevalent but not well recognised in patients with pSS. Objectives Our aim is to determine the existence of cytopenia at diagnosis or during follow-up of our pSS patients as well as the associated factors. Methods A cohort of pSS patients that had been followed-up in the Department of Rheumatology, Tongji hospital of Tongji University, from 2011 to 2017 was retrospectively assessed. Clinical and laboratory findings about the patients were recorded. Results Out of 232 pSS patients composing the cohort, cytopenia was already present in 55.60% (n=129) at the time of diagnosis. Anaemia was detected in 30.17% (n=70), leukopenia in 37.5% (n=87), neutropenia in 22.41% (n=52), and thrombocytopenia in 26.72% (n=62) of patients. The proportion of patients with cumulative cytopenia was 6.47% (n=15). Cumulative cytopenia was disease-related in 5.60% (n=13) and medication-related in 0.86% (n=2) of the patients. In patients with cytopenia at the time of diagnosis, erythrocyte sedimentation rates (ESR) were higher (p<0.001), C3 and C4 hypocomplementemia was more prevalent (p<0.001, p=0.060), and they were positive for anti-SSB at a greater proportionand (p=0.058). Hyperglobulinemia, C3 hypocomplementemia, positive anti-SSA and anti-SSB might increase the incidence of anaemia in pSS, with OR of 2.700, 2.042, 1.537 and 1.901, respectively. In addition, logistic regression analysis suggest C3 hypocomplementemia might be associated with different types Leukopenia(p<0.01), while abnormal Transaminase and C4 hypocomplementemia are independent risk factors for thrombocytopenia with a OR of 4.171 (1.516–11.480) and 5.697 (1.662–19.523). Cytopenia in pSS patients not either at diagnosis or during follow-up, was always easy to be ameliorated, but several cases leaded to unfavourable outcome. Conclusions The most common haematological disorders in pSS patients are leukopenia, and cytopenia in pSS patients might be related to disease activity. References [1] Tim Both, et al. Reviewing primary Sjögren’s syndrome: beyond thedryness – From pathophysiology to diagnosis and treatment. Int. J. Med. Sci. 2017, 14(3): 191–200. [2] García-Carrasco M, et al. Serologic features of primary Sjögren’s syndrome: Clinical and prognostic correlation. Int J Clin Rheumtol2012;7(6):651–659. Acknowledgements We would like to thank all of the participants who took part in the studies featured in this research. The present work was sponsored by the National Natural Science Foundation of China (No. 81273295, 81302562, 81671598), China International Medical Exchange Foundation (Z-2014–06–2–1620), and Shanghai Sailing Program (No.17YF1417200). Disclosure of Interest None declared

A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience

Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort

Renal involvement and followup of 130 patients with primary Sjögren's syndrome.

Long-term survival analysis of patients with primary Sjögren's syndrome in China: A multicenter retrospective cohort study

Clinical features and outcomes from the Singapore Sjögren's syndrome study

AB0461 A Retrospective Study of Primary Sjogren's Syndrome Patients with Cancer in Chinese Population: A Single-Center Experience

Primary Sjögren's syndrome: Longitudinal real-world, observational data on health-related quality of life

Sjögren's syndrome: one year in review 2023

Characteristics And Mortality In Primary Sjogren Syndrome-Related Interstitial Lung Disease

Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development

Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development

The clinical characteristics of 573 cases of primary Sj(o)gren's syndrome

Prognosis of Single Implant-Supported Prosthesis in Patients With Primary Sjögren's Syndrome: A Five-Year Prospective Clinical Study

The association between primary Sjogren's syndrome and non-Hodgkin's lymphoma: a systematic review and meta-analysis of cohort studies

Long-term renal prognosis among patients with primary Sjögren's syndrome and renal involvement: A nationwide matched cohort study

AB0637 Haematological Involvement of Primary Sjogren’s Syndrome Patients in a Single Centre Study of 232 Chinese Cases

Clinical and pathological characteristics of 141 patients of primary Sjogren's syndrome with renal involvement

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients

Five-year outcome in immune-mediated scleritis

Childhood-onset primary Sjögren's syndrome in a tertiary center in China: Clinical features and outcome

Patients with Early-Onset Primary Sjögren’s Syndrome Have Distinctive Clinical Manifestations and Circulating Lymphocyte Profiles